If you had invested $ 1,000.00 (change) years ago 5 years, ago, you would now have:
type |
Ex - Dividend Date |
payment date |
value |
|---|---|---|---|
| Dividends | 12/30/2021 | 12/31/2021 | 1,85334000 |
| Dividends | 12/31/2020 | 01/04/2021 | 0,28812000 |
| Dividends | 12/29/2017 | 01/02/2018 | 0,35020000 |
| Dividends | 12/31/2015 | 01/04/2016 | 0,10551000 |
Average Investor10 user rating
4.0
(1 people)
Loncar Cancer Immunotherapy ETF (United States) is an exchange-traded fund (ETF), with assets under management totaling $6.95 M.
Over the past 12 months, Loncar Cancer Immunotherapy ETF recorded a return of 0.00%, with its price trading between $0.00 and $10.17 during the same period.
The ETF is traded under the ticker CNCR.
The current price of CNCR is $ 0.00, representing a 0.00% gain over the past year. The ETF began the year trading around $ 0.00% and is currently priced at $ 0.00. You can track the real-time price chart, review historical performance, and access detailed information about this ETF on the platform.
CNCR is currently trading at $ 0.00, with a market capitalization of approximately $6.946.185,00. Over the past year, the ETF has delivered a 0.00% return, based on share price performance.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
You can invest in CNCR through a brokerage account that provides access to the exchange where it is listed. After opening and funding your account, search for the ticker symbol CNCR, select the number of shares you wish to purchase, and place your order.
In certain markets, similar exposure may also be available through locally listed products that track the same index.
Over the past month, CNCR has returned 0.00%, and 0.00% over the past year.
If you were to purchase 100 shares of CNCR at the current price of $ 0.00, your total investment would be $ 0.00.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
Register
Already have an account? Login
Register
Register for free to continue accessing Investor10.
Already have an account? Login
Tesla
Dividend Calendar
Stock Rankings
ETF Rankings
Crypto Rankings
